EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY Equipe constitutive de l'UMR1027, unité mixte INSERM - Université Toulouse III Paul Sabatier
 

2020
  • Delcourt N, Lanot T, Vardon-Bounes F, Gandia P, Franchitto N. Severe Metabolic Failures After Recreational Ingestion of γ-Butyrolactone. J Clin Psychopharmacol. 2020 Nov/Dec;40(6):624-626. doi: 10.1097/JCP.0000000000001276.
     
  • Dufayet L, Monnet F, Laborde-Casterot H, Caré W, Lekens B, Langrand J; Mégarbane B, Vodovar D. French Poison Control Centers Research Network (Franchitto N collaborator). Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French Poison Control Center study. Clin Toxicol (Phila). 2020 Oct 2:1-7. doi: 10.1080/15563650.2020.1822530.
     
  • Franchitto N. Buprenorphine poisoning in children: a 10-year experience of Marseille Poison Center. Fundam Clin Pharmacol. 2020;34(2):263‐264. doi:10.1111/fcp.12547.
     
  • Franchitto N. Complications somatiques du cannabis [Cannabis use and somatic consequences]. Rev Prat. 2020 Jan;70(1):69-77. PMID: 32877036.
     
  • Franchitto N. Methadone poisonings: a seven-year retrospective study of the French poison center network focusing on suicide attempt vs. misuses. Fundam Clin Pharmacol. 2020 Apr;34(2):288-289. doi: 10.1111/fcp.12545.
     
  • Rolland B, Simon N, Franchitto N, Aubin HJ. France Grants an Approval to Baclofen for Alcohol Dependence. Alcohol Alcohol. 2020 Feb 7;55(1):44-45. doi: 10.1093/alcalc/agz08.
     
  • Salles J, Lacassagne E, Eddiry S, Franchitto N, Salles JP, Tauber M. What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders? Mol Psychiatry. 2020 Oct 20. doi: 10.1038/s41380-020-00917-x. Epub ahead of print.
     
  • Salles J, Mariaux N, Franchitto N, Sourdet S, Arbus C. Substance use disorder in the elderly and specified DSM-5 criteria. Geriatr Psychol Neuropsychiatr Vieil. 2020 Jun 1;18(2):197-204.  doi: 10.1684/pnv.2020.0858.
2019
  • Jouanjus E, Lapeyre-Mestre M, Nodot M, Roussin A, Franchitto N, Boyes JP, Nasr N, Oustric S, Dupouy J. Teaching Basic Knowledge on Substance Use Disorders: The Impact of e-Learning on Health Professionals. Clin Ther. 2019 Oct;41(10):2154-2161. doi: 10.1016/j.clinthera.2019.07.012.
     
  • de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo  F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley  KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford  A, Thompson A, van den Brink  W , Leggio  L, Agabio  R. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective. Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708.
     
  • Karila L, Marillier M, Chaumette B, Billieux J, Franchitto N, Benyamina A. New synthetic opioids: Part of a new addiction landscape. Neurosci Neurosci Biobehav Rev. 2019 Nov;106:133-140. doi: 10.1016/j.neubiorev.2018.06.010.
     
  • Labadie M, Rebouissoux L, Viala J, Nisse P, Vodovar D, Courtois A, Gallart JC , Glaizal M, Denoyelle F, Franchitto N, Manel J , Lamireau T, Puskarczyk E. Regarding pH-neutralizing esophageal irrigations as a novel mitigation strategy for button battery injury. Laryngoscope. 2019;129(4):E123‐E124. doi:10.1002/lary.27728.
     
  • Vayr F, Herin F, Jullian B, Soulat JM, Franchitto N. Barriers to seeking help for physicians with substance use disorder: A review. Drug Alcohol Depend. 2019 Jun 1;199:116-121. doi: 10.1016/j.drugalcdep.2019.04.004.